NIH Announcements
This section contains pertinent notices of NIH Policy Changes regarding the administration and management of NIH-funded research. This is not meant to be a comprehensive list. For more information, please visit the following link: https://grants.nih.gov/policy-and-compliance/notice-of-policy-changes
NIH’s Implementation of Common Forms for Biographical Sketch and Current and Pending (Other) Support for Due Dates on or after January 25, 2026 Notice Number: NOT-OD-26-018 | In an effort to support strong collaboration between Federal research agencies, NIH is adopting the Common Forms for Biographical Sketch and Current and Pending (Other) Support as per the White House Office of Science and Technology Policy (OSTP) memorandum on Policy Regarding Use of Common Disclosure Forms. This Guide Notice provides details for the Common Forms, NIH Biographical Sketch Supplement, and instructions required for use for application due dates and Research Performance Progress Report (RPPR) submissions on or after January 25, 2026.
An important reminder: institutions must maintain internal controls (e.g., policies and procedures) for disclosure, which must include training on these policies and procedures for senior/key personnel. Availability of Forms and Instructions: A preview of the Biographical Sketch Common Form, NIH Biographical Sketch Supplement, and Current and Pending (Other) Support Common Form and instructions are currently available in Science Experts Network Curriculum Vitae (SciENcv) (see Guide Notice NOT-OD-25-152). NIH anticipates finalizing the templates in SciENcv for Common Forms, the NIH Biographical Sketch Supplement and associated instructions the week of December 15, 2025. |
Research Security Training Requirements for NIH | This notice notifies the extramural community of the NIH implementation of the Research Security Training (RST) requirements outlined in the CHIPS and Science Act of 2022 (P.L. 117-167). In accordance with Section 10634 of Act, each covered individual (for NIH this is defined as senior/key personnel) listed on an NIH grant application must certify that they have completed RST within 12 months of the date of application submission. NIH does not collect Current and Pending (Other) Support at the time of application based on our Just-in-Time policy. Therefore, NIH will collect the individual certification at the time of the application submission, through the Biographical Sketch in SciENcv. The Act also requires applicant institutions to certify that each covered individual who is employed by the institution and listed on the application has completed RST. The Authorized Organization Representative (AOR), via their signature on the face page of the application, will certify the applicant institution’s compliance with this requirement. Applicants and recipients may utilize any training that addresses cybersecurity, international collaboration, foreign interference, and rules for proper use of funds, disclosure, conflict of commitment, and conflict of interest. NSF, in partnership with the National Institutes of Health (NIH), the Department of Energy (DOE) and the Department of Defense (DOD), have provided four online RST modules as a resource to the extramural community. Subsequently, the SECURE Center developed an updated and condensed version of the four modules. The condensed RST module is designed to meet the government-wide RST requirement in Section 10634 of the CHIPS and Science Act of 2022 (42 U.S.C. § 19234). To that end, NIH also recognizes completion of the condensed module as compliant with the respective RST requirements. Effective Date: At this time, the research security training requirement is optional. Completion of RST and the individual and institutional certifications will be effective for applications submitted for due dates on or after May 25, 2026. |
Interim Guidance on Reopening of NIH Extramural Activities | NIH is working to reestablish dates for grant and contract submissions, determine how to communicate details related to missed review meetings, reschedule dates for training, and other activities that were scheduled to occur during and immediately following the period of the government shutdown.
As of today, we can confirm that we will be rescheduling all October and November grant application submission deadlines (specific dates to be announced in a future Notice). By delaying due dates that occurred both during the lapse in funding and in the week following, applicants will have access to NIH staff and the help desks as they develop their applications. Peer review meetings that were scheduled to take place between October 1 and November 14 have been cancelled and will be rescheduled, details to come. Additionally, council meetings that were scheduled to take place between October 1 and November 14 were cancelled and will be rescheduled, details to come. During the shutdown, the eRA system remained open and available to accept application submissions. As such, eRA is currently reviewing service desk ticket requests from entities and individuals that needed assistance with login and passwords. eRA staff will address the tickets on a first come, first serve basis. Please note that due to the volume the response time may be longer than usual. The eRA system was also available for recipients to submit Research Performance and Progress Reports, Federal Financial Reports, etc. The email reminders and submission confirmations were held and will be sent out in the coming weeks. If you submitted any reports during this time, no additional action is required unless you are contacted by NIH staff. NIH will provide additional information, including a Notice on NIH operations during a continuing resolution, as soon as it is available. |
| Information for the NIH Extramural Community During the Lapse of Federal Grant Funding
Notice Number: NOT-OD-26-004 | This notice provides guidance on available functions of NIH during the current government shutdown.
Federal grant submission deadlines are still in effect. As such, PAVIR continues to submit federal proposals. |
| RESCINDED – Implementation of NIH Research Security Policies
Notice Number: NOT-OD-25-154 | This notice rescinds the implementation of NIH Research Security Training for all Senior/Key personnel on NIH grants or cooperative agreements. PAVIR will continue to monitor this topic and will provide updates as they become available.
|
| No-Cost Extension Functionality in eRA Notice Number: NOT-OD-25-142 Release Date: August 7, 2025 Source: NOT-OD-25-142: Update: No-Cost Extension Functionality in eRA | This notice provides an update on the guidance issued inNOT-OD-25-110. Effective with the issuance of this Guide Notice, NIH has re-enabled the No-Cost Extension functionality within eRA Commons. Recipients may resume initiating first no-cost extensions in eRA Commons, in accordance with the NIH Grants Policy Statement, Section 8.1.1.3. Requests that were previously submitted via the prior approval module will not be reviewed, and recipients will need to initiate the first no cost extension within the Status module by using the Extension action.
If you believe this affects your PAVIR-administered NIH-funded award, please contact your assigned Post-Award Contract and Grant Analyst for further details. |
| How Does the NIH Initiative to Prioritize Human-Based Research Affect Research Proposing the Use of Laboratory Animals?
July 18, 2025 | In July 2025,NIH announced it will no longer develop new funding opportunities focused exclusively on animal models of human disease. Rather, going forward, new funding opportunities will be designed more broadly with language that also encourages various approaches be considered. This means researchers may choose any model they deem appropriate – including a combination of approaches – to answer a research question when submitting applications seeking NIH support. This strategy is intended to open the possibilities of which types of models can be submitted in response to funding opportunities, not be restrictive or prescriptive.
Applicants may continue to propose research exclusively involving human participants (like clinical trials), particular laboratory animals, real-world data, in vitro methods, mathematical models, artificial intelligence, in silico approaches, other alternative approaches, or a combination of models. Peer reviewers will assess, through our fair and impartial review process, the merit of each approach proposed, its relevance to human disease, and if it is best suited to answering the research question that advances biomedical research and discovery. Our overarching goal is to accelerate progress, encourage innovation, and ultimately improve the quality and validation of new approach methodologies. We are also prioritizing human-based technologies and models, where scientifically valid and justified. Likewise, funding opportunities will indicate a special emphasis on human-based approaches. These steps should encourage investigators to choose the best models for their research without constraints. To reiterate, NIH will continue to support grants that use laboratory animal models if scientifically appropriate, justifiable, and with appropriate animal welfare oversight. Moreover, if laboratory animals are proposed, scientists must still continue to clearly explain why they are necessary for their research, that the minimal number needed to ensure rigorous and reproducible studies will be used, and why the study cannot be done using another model or approach (see more here). While traditional animal models continue to be important to advancing scientific knowledge, NIH recognizes that prioritizing new and emerging human-based technologies can offer unique strengths to expand the toolbox for researchers to answer previously difficult or unanswerable biomedical research questions. It also moves us toward our continued long-term goal of reducing, refining, and replacing the use of laboratory animals in NIH-supported research. |
Updated Implementation Guidance on NIH Policy on Foreign Subawards for Active Projects | Taking into consideration concerns for patient safety risks for ongoing projects, NIH recognized the need to identify an alternative approach for removing the foreign subawards from existing grants and cooperative agreements involving human subjects research (e.g., clinical trials and clinical research) at the foreign site. As a result, NIH Institutes, Centers, and Offices (ICOs) will have the option to renegotiate the award structure with a recipient such that foreign subawards are financially removed from the primary award and awarded as administrative supplement (i.e., Type 3) awards. Each foreign supplement award will only include funds allocated for a single foreign entity, allowing NIH better ability to track obligations to foreign entities.
Please contact your assigned PAVIR Post-Award Contract and Grant Analyst (CGA) if you have further questions or concerns on how this affects your PAVIR-administered NIH award. |
|
Supporting Fairness and Originality in NIH Research Applications | NIH will not consider applications that are either substantially developed by AI, or contain sections substantially developed by AI, to be original ideas of applicants.
NIH will only accept 6 new, renewal, resubmission, or revision applications from an individual Principal Investigator/Program Director or Multiple Principal Investigator for all council round sin a calendar year. This applies to all activity codes except T activity codes and R13 Conference Grant applications. PAVIR will be monitoring the number of submissions per PI to NIH to ensure that the maximum number of proposals to be submitted is not exceeded. |
|
NIH Announces a New Policy Requirement to Train Senior/Key Personnel on Other Support Disclosure | This Guide Notice announces a new policy requirement that requires NIH recipients to provide training to all faculty and researchers identified asSenior/Key Personnel on the requirement to disclose all research activities and affiliations (active and pending) in Other Support (see Other Support form). The new requirement to train researchers to comply with other support disclosure requirements adds to the current policy (see NIH Grants Policy Statement (GPS), Section 2.5.1 "Just-in-Time Procedures") in order to provide a comprehensive plan in the area of disclosure requirements for recipients. This update will be included in the FY2026 version of the NIH GPS as part of NIH’s standard processes.
PAVIR is still in discussion on how it will implement this new requirement going forward. Communication to the PI community will be sent once this has been finalized. |
